(HRL) Hormel Foods - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4404521001
Canned Meats, Nut Butters, Deli Meats, Bacon, Chili
Dividends
| Dividend Yield | 5.97% |
| Yield on Cost 5y | 3.57% |
| Yield CAGR 5y | 4.99% |
| Payout Consistency | 92.3% |
| Payout Ratio | 110.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.4% |
| Value at Risk 5%th | 38.0% |
| Relative Tail Risk | -5.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.92 |
| Alpha | -25.32 |
| CAGR/Max DD | -0.34 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.706 |
| Beta | 0.077 |
| Beta Downside | 0.021 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.89% |
| Mean DD | 26.14% |
| Median DD | 29.22% |
Description: HRL Hormel Foods October 30, 2025
Hormel Foods Corp. (NYSE:HRL) manufactures and distributes a broad portfolio of meat, nut, and convenience-food products to food-service, retail, and international customers, organized into Retail, Foodservice, and International segments.
The company’s product mix spans fresh meats, frozen and refrigerated meals, and shelf-stable items such as canned meats, nut butters, and microwaveable entrees, marketed under well-known brands including Hormel, Spam, Skippy, and Applegate.
Key performance indicators that analysts watch include HRL’s 2023 net sales of $12.6 bn, a 5-year average operating margin of ~13 %, and a free cash flow conversion rate of roughly 75 %, which underpins its consistent dividend growth (13 % CAGR over the past decade).
Sector-level drivers remain strong: U.S. protein demand is growing at ~2 % annually, while inflationary pressure on commodity inputs (pork, beef) is partially offset by pricing power in branded, value-added products.
Hormel’s international exposure-about 15 % of total revenue-offers upside as emerging-market middle-class consumption of processed protein rises faster than in mature markets.
For a deeper quantitative breakdown of Hormel’s valuation metrics, the ValueRay platform provides a granular view of its forward earnings multiples and segment cash-flow trends.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (754.5m TTM) > 0 and > 6% of Revenue (6% = 723.5m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -2.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.39% (prev 14.09%; Δ 2.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 931.0m > Net Income 754.5m (YES >=105%, WARN >=100%) |
| Net Debt (2.26b) to EBITDA (1.30b) ratio: 1.73 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.47 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (550.4m) change vs 12m ago 0.21% (target <= -2.0% for YES) |
| Gross Margin 16.32% (prev 16.82%; Δ -0.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 90.63% (prev 91.36%; Δ -0.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.40 (EBITDA TTM 1.30b / Interest Expense TTM 77.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.81
| (A) 0.15 = (Total Current Assets 3.32b - Total Current Liabilities 1.35b) / Total Assets 13.50b |
| (B) 0.57 = Retained Earnings (Balance) 7.73b / Total Assets 13.50b |
| (C) 0.08 = EBIT TTM 1.04b / Avg Total Assets 13.31b |
| (D) 1.38 = Book Value of Equity 7.47b / Total Liabilities 5.40b |
| Total Rating: 4.81 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.92
| 1. Piotroski 5.0pt |
| 2. FCF Yield 4.18% |
| 3. FCF Margin 5.21% |
| 4. Debt/Equity 0.35 |
| 5. Debt/Ebitda 1.73 |
| 6. ROIC - WACC (= 2.19)% |
| 7. RoE 9.39% |
| 8. Rev. Trend -51.92% |
| 9. EPS Trend -81.15% |
What is the price of HRL shares?
As of December 08, 2025, the stock is trading at USD 24.34 with a total of 4,894,754 shares traded.
Over the past week, the price has changed by +4.87%, over one month by +12.95%, over three months by -3.97% and over the past year by -22.82%.
Over the past week, the price has changed by +4.87%, over one month by +12.95%, over three months by -3.97% and over the past year by -22.82%.
Is HRL a buy, sell or hold?
Hormel Foods has received a consensus analysts rating of 3.25.
Therefor, it is recommend to hold HRL.
- Strong Buy: 1
- Buy: 1
- Hold: 10
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HRL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.4 | 8.6% |
| Analysts Target Price | 26.4 | 8.6% |
| ValueRay Target Price | 22.3 | -8.4% |
HRL Fundamental Data Overview December 05, 2025
Market Cap USD = 12.80b (12.80b USD * 1.0 USD.USD)
P/E Trailing = 16.8623
P/E Forward = 17.2712
P/S = 1.0614
P/B = 1.5854
P/EG = 3.508
Beta = 0.333
Revenue TTM = 12.06b USD
EBIT TTM = 1.04b USD
EBITDA TTM = 1.30b USD
Long Term Debt = 2.85b USD (from longTermDebt, last quarter)
Short Term Debt = 6.74m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.26b USD (from netDebt column, last quarter)
Enterprise Value = 15.02b USD (12.80b + Debt 2.86b - CCE 630.7m)
Interest Coverage Ratio = 13.40 (Ebit TTM 1.04b / Interest Expense TTM 77.9m)
FCF Yield = 4.18% (FCF TTM 627.7m / Enterprise Value 15.02b)
FCF Margin = 5.21% (FCF TTM 627.7m / Revenue TTM 12.06b)
Net Margin = 6.26% (Net Income TTM 754.5m / Revenue TTM 12.06b)
Gross Margin = 16.32% ((Revenue TTM 12.06b - Cost of Revenue TTM 10.09b) / Revenue TTM)
Gross Margin QoQ = 16.07% (prev 16.71%)
Tobins Q-Ratio = 1.11 (Enterprise Value 15.02b / Total Assets 13.50b)
Interest Expense / Debt = 0.68% (Interest Expense 19.5m / Debt 2.86b)
Taxrate = 22.33% (52.8m / 236.5m)
NOPAT = 810.3m (EBIT 1.04b * (1 - 22.33%))
Current Ratio = 2.47 (Total Current Assets 3.32b / Total Current Liabilities 1.35b)
Debt / Equity = 0.35 (Debt 2.86b / totalStockholderEquity, last quarter 8.08b)
Debt / EBITDA = 1.73 (Net Debt 2.26b / EBITDA 1.30b)
Debt / FCF = 3.60 (Net Debt 2.26b / FCF TTM 627.7m)
Total Stockholder Equity = 8.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.59% (Net Income 754.5m / Total Assets 13.50b)
RoE = 9.39% (Net Income TTM 754.5m / Total Stockholder Equity 8.03b)
RoCE = 9.58% (EBIT 1.04b / Capital Employed (Equity 8.03b + L.T.Debt 2.85b))
RoIC = 7.44% (NOPAT 810.3m / Invested Capital 10.89b)
WACC = 5.25% (E(12.80b)/V(15.66b) * Re(6.30%) + D(2.86b)/V(15.66b) * Rd(0.68%) * (1-Tc(0.22)))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.20%
[DCF Debug] Terminal Value 77.26% ; FCFE base≈737.8m ; Y1≈689.8m ; Y5≈639.7m
Fair Price DCF = 20.85 (DCF Value 11.47b / Shares Outstanding 550.0m; 5y FCF grow -8.30% → 3.0% )
EPS Correlation: -81.15 | EPS CAGR: -9.55% | SUE: -1.96 | # QB: 0
Revenue Correlation: -51.92 | Revenue CAGR: -3.41% | SUE: 0.81 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.31 | Chg30d=-0.019 | Revisions Net=-5 | Analysts=6
EPS next Year (2026-10-31): EPS=1.44 | Chg30d=-0.062 | Revisions Net=-9 | Growth EPS=+5.4% | Growth Revenue=+2.1%
P/E Trailing = 16.8623
P/E Forward = 17.2712
P/S = 1.0614
P/B = 1.5854
P/EG = 3.508
Beta = 0.333
Revenue TTM = 12.06b USD
EBIT TTM = 1.04b USD
EBITDA TTM = 1.30b USD
Long Term Debt = 2.85b USD (from longTermDebt, last quarter)
Short Term Debt = 6.74m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.26b USD (from netDebt column, last quarter)
Enterprise Value = 15.02b USD (12.80b + Debt 2.86b - CCE 630.7m)
Interest Coverage Ratio = 13.40 (Ebit TTM 1.04b / Interest Expense TTM 77.9m)
FCF Yield = 4.18% (FCF TTM 627.7m / Enterprise Value 15.02b)
FCF Margin = 5.21% (FCF TTM 627.7m / Revenue TTM 12.06b)
Net Margin = 6.26% (Net Income TTM 754.5m / Revenue TTM 12.06b)
Gross Margin = 16.32% ((Revenue TTM 12.06b - Cost of Revenue TTM 10.09b) / Revenue TTM)
Gross Margin QoQ = 16.07% (prev 16.71%)
Tobins Q-Ratio = 1.11 (Enterprise Value 15.02b / Total Assets 13.50b)
Interest Expense / Debt = 0.68% (Interest Expense 19.5m / Debt 2.86b)
Taxrate = 22.33% (52.8m / 236.5m)
NOPAT = 810.3m (EBIT 1.04b * (1 - 22.33%))
Current Ratio = 2.47 (Total Current Assets 3.32b / Total Current Liabilities 1.35b)
Debt / Equity = 0.35 (Debt 2.86b / totalStockholderEquity, last quarter 8.08b)
Debt / EBITDA = 1.73 (Net Debt 2.26b / EBITDA 1.30b)
Debt / FCF = 3.60 (Net Debt 2.26b / FCF TTM 627.7m)
Total Stockholder Equity = 8.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.59% (Net Income 754.5m / Total Assets 13.50b)
RoE = 9.39% (Net Income TTM 754.5m / Total Stockholder Equity 8.03b)
RoCE = 9.58% (EBIT 1.04b / Capital Employed (Equity 8.03b + L.T.Debt 2.85b))
RoIC = 7.44% (NOPAT 810.3m / Invested Capital 10.89b)
WACC = 5.25% (E(12.80b)/V(15.66b) * Re(6.30%) + D(2.86b)/V(15.66b) * Rd(0.68%) * (1-Tc(0.22)))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.20%
[DCF Debug] Terminal Value 77.26% ; FCFE base≈737.8m ; Y1≈689.8m ; Y5≈639.7m
Fair Price DCF = 20.85 (DCF Value 11.47b / Shares Outstanding 550.0m; 5y FCF grow -8.30% → 3.0% )
EPS Correlation: -81.15 | EPS CAGR: -9.55% | SUE: -1.96 | # QB: 0
Revenue Correlation: -51.92 | Revenue CAGR: -3.41% | SUE: 0.81 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.31 | Chg30d=-0.019 | Revisions Net=-5 | Analysts=6
EPS next Year (2026-10-31): EPS=1.44 | Chg30d=-0.062 | Revisions Net=-9 | Growth EPS=+5.4% | Growth Revenue=+2.1%
Additional Sources for HRL Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle